A new HAY FEVER breakthrough clinically proven tds to reduce allergy symptoms and antihistamine use. How long were symptoms reduced? Studies showed 1 a one-year reduction. How long? Yes, one year! this medication is a lozenge taken twice daily for 21 days. this medication is non-drowsy, natural and available without a prescription. this testers medication is a 21 day treatment. this medication users report reductions in symptoms one year after completing tds and 1 the treatment without taking additional this medication. How long? Yes one year, compared to 24-hour antihistamines it''s much longer lasting. Patients known to have seasonal allergy were examined in clinical studies in five U.S. states by qualified medical doctors. Each patient was given either the real this medication or a placebo (a dummy treatment). Nobody knew who got what. Patients recorded in symptons diaries how bad their symptoms were during and testers after the treatment. About one year later, patients completed a second diary. 64% of the group of patients receiving this medication recorded less sneezing, runny nose and nasal congestion one tds year after completing the treatment in a clinical 1 study. This compares to 35% of the placebo group.

In 1992 in El Paso, TX a randomized, double-blind, placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 testers and tds was conducted. The average IgE level of the placebo treated subjects remained essentially flat, while the average IgE level for active treated 1 subjects was reduced significantly from baseline testers to Day 30.7 In 1993 in El Paso, TX, valid tds subjects (n=66) returned a second set of 1 symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). The active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. The placebo group had increased symptoms in 1993. (The relevant testers pollen counts at the study site in 1993 were much higher than in 1992, leading tds to expectation 1 of higher symptoms.)7

Genentech and Novartis are developing an anti-IgE monoclonal antibody for testers asthma tds and allergic rhinitis. In December 1999 they announced positive study results. This is evidence that reducing IgE results in a reduction of symptoms associated with IgE-mediated allergic disease.13 For people who find they cannot 1 adequately avoid the allergens, the symptoms often can be controlled with medications. Effective medications that can be prescribed by a physician include antihistamines, topical nasal steroids, and cromolyn sodium - testers any of which can be used alone or in combination. tds and 1 Many effective antihistamines and decongestants also are available without a prescription. Click here for allergy medication online testers.